Wellset Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -66.23%
- Profit Growth -0.59%
- Ebitda -61.37%
- Net Worth 23.65%
- Total Assets 34.01%
About Wellset Pharma
Wellset Pharma Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 November 2020 (Four years and three months 22 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ghufran Nomani, Saleem, and Tarannum serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909HR2020PTC090649
- Company No.
090649
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Wellset Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ghufran Nomani  | Director | 27-Aug-2024 | Current |
| Saleem | Director | 03-Nov-2020 | Current |
| Tarannum | Director | 03-Nov-2020 | Current |
Financial Performance of Wellset Pharma.
Wellset Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 66.23% decrease. The company also saw a slight decrease in profitability, with a 0.59% decrease in profit. The company's net worth Soared by an impressive increase of 23.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellset Pharma?
Unlock access to Wellset Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gpg Healthcare Private LimitedGhufran Nomani is a mutual person
- Numedisure Private Limited
Ghufran Nomani is a mutual person
- Manavta Hospitals Private Limited
Ghufran Nomani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellset Pharma?
Wellset Pharma has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellset Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellset Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.